本页面由Tiger Trade Technology Pte. Ltd.提供服务

朴荷生物科技

1.67
-0.0100-0.60%
成交量:3.43万
成交额:5.47万
市值:537.82万
市盈率:-0.04
高:1.69
开:1.66
低:1.50
收:1.68
52周最高:2,074.50
52周最低:1.50
股本:322.05万
流通股本:278.95万
量比:0.71
换手率:1.23%
股息:- -
股息率:- -
每股收益(TTM):-37.4010
每股收益(LYR):0.9571
净资产收益率:-729.77%
总资产收益率:-298.12%
市净率:1.27
市盈率(LYR):1.74

数据加载中...

2026/03/02

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/01/23

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/12/05

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/09/25

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/09/19

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2025/07/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/24

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/12/20

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/12/20

SEC问询函

Form CORRESP - Correspondence
2024/12/20

SEC问询函

Form CORRESP - Correspondence
2024/12/06

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/12/03

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/11/06

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/10/09

SEC问询函

Form CORRESP - Correspondence
2024/10/09

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/09/18

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/09/18

SEC问询函

Form CORRESP - Correspondence
2024/08/26

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/08/26

SEC问询函

Form CORRESP - Correspondence